TRIDOSS LABORATORIES PVT. LTD. AND ANR vs UNION OF INDIA AND 2 ORS Advocate - GP OS, RESP. NO. 1,RESPONDENT NO. 2 AND 3,D P SINGH — WP/2789/2017
Case under Essential Commodities Act. Disposed: Contested--DISPOSED OFF on 15th April 2026.
CNR: HCBM020282672017
Filing Number
WP/3250/2017
Filing Date
20-Nov-2017
Registration No
WP/2789/2017
Registration Date
22-Nov-2017
Judge
Hon'ble Shri Justice Manish Pitale , Hon'ble Shri Justice Shreeram Vinayak Shirsat
Coram
Hon'ble Shri Justice Manish Pitale , Hon'ble Shri Justice Shreeram Vinayak Shirsat
Bench Type
Division
Category
ORDINARY CIVIL ( 30 )
Judicial Branch
Original
Decision Date
15-Apr-2026
Nature of Disposal
Contested--DISPOSED OFF
Last updated 25-May-2026
Acts & Sections
Petitioner(s)
-
1.TRIDOSS LABORATORIES PVT. LTD. AND ANR
Adv. VM LEGAL
-
2.AKHTAR SHAMSI
Respondent(s)
-
1.UNION OF INDIA AND 2 ORS Advocate - GP OS, RESP. NO. 1,RESPONDENT NO. 2 AND 3,D P SINGH
-
2.THE COLLECTOR MUMBAI CITY
-
3.THE TAHSILDAR (GOVT. DUES RECOVERY)
Case History
-
Case disposedDisposed
-
15-Apr-2026
Hon'ble Shri Justice Manish Pitale,hon'ble Shri Justice Shreeram Vinayak ShirsatView PDF
Summary The Bombay High Court quashed demand notices issued by the Union of India (Department of Pharmaceuticals) against Tridoss Laboratories for alleged overcharging of a pharmaceutical product (Phylobid CR 300 mg), citing gross delay of over 10 years in initiating proceedings and violation of natural justice principles. The court found the government's action unsustainable as it prevented the company from defending itself due to unavailable records and failed to properly consider the company's defense that the specific drug formulation was never subject to price controls. This case analysis is maintained by casestatus.in based on publicly available court records.
-
16-Mar-2026
Hon'ble Shri Justice Manish Pitale,hon'ble Shri Justice Shreeram Vinayak ShirsatView PDF
-
16-Mar-2026
High On Board -
Hon'ble Shri Justice Manish Pitale , Hon'ble Shri Justice Shreeram Vinayak Shirsat
-
10-Mar-2026
Hon'ble Shri Justice Manish Pitale,hon'ble Shri Justice Shreeram Vinayak ShirsatView PDF
-
10-Mar-2026
At 01.00 Pm
Hon'ble Shri Justice Manish Pitale , Hon'ble Shri Justice Shreeram Vinayak Shirsat
-
06-Mar-2026
Hon'ble Shri Justice Manish Pitale,hon'ble Shri Justice Shreeram Vinayak ShirsatView PDF
-
06-Mar-2026
Bottom Of The Board
Hon'ble Shri Justice Manish Pitale , Hon'ble Shri Justice Shreeram Vinayak Shirsat
-
04-Mar-2026
Hon'ble Shri Justice Manish Pitale,hon'ble Shri Justice Shreeram Vinayak ShirsatView PDF
-
04-Mar-2026
For Admission
Hon'ble Shri Justice Manish Pitale , Hon'ble Shri Justice Shreeram Vinayak Shirsat
-
09-Jan-2026
Hon'ble Shri Justice Manish Pitale,hon'ble Shri Justice Shreeram Vinayak ShirsatView PDF
-
10-Sep-2020
For Admission
According To Sitting List
-
11-Jul-2018
Hon'ble Shri Justice A.S. GadkariView PDF
-
11-Jul-2018
For Admission
Hon'ble Smt. Justice Anuja Prabhudessai , Hon'ble Shri Justice Ranjit More.
-
06-Jun-2018
Hon'ble Shri Justice A.S. GadkariView PDF
-
06-Jun-2018
For Admission
Hon'ble Smt. Justice Anuja Prabhudessai , Hon'ble Shri Justice Ranjit More.
-
11-Apr-2018
For Admission
Hon'ble Smt. Justice S.S. Jadhav , Hon'ble Shri Justice Ranjit More.
-
22-Dec-2017
Hon'ble Shri Justice Rajesh G. Ketkar,hon'ble Shri Justice Shantanu S. KemkarView PDF
-
22-Dec-2017
Fresh Admission
Hon'ble Shri Justice Rajesh G. Ketkar , Hon'ble Shri Justice Shantanu S. Kemkar
-
22-Nov-2017
Hon'ble Shri Justice G. S. Kulkarni,hon'ble Shri Justice Shantanu S. KemkarView PDF
-
22-Nov-2017
First hearing
Initial hearing scheduled
-
20-Nov-2017
Case filed
Registration No. WP/2789/2017
Summary The Bombay High Court quashed demand notices issued by the Union of India (Department of Pharmaceuticals) against Tridoss Laboratories for alleged overcharging of a pharmaceutical product (Phylobid CR 300 mg), citing gross delay of over 10 years in initiating proceedings and violation of natural justice principles. The court found the government's action unsustainable as it prevented the company from defending itself due to unavailable records and failed to properly consider the company's defense that the specific drug formulation was never subject to price controls. This case analysis is maintained by casestatus.in based on publicly available court records.
Explore other courts